Erwin WM, Las Heras F, Islam D, Fehlings MG, Inman RD: The regenerative capacity of the notochordal cell: tissue constructs generated in vitro under hypoxic conditions
According to NICE guidelines, maintaining good glycaemic control is essential for reducing the risk of both microvascular and macrovascular complications
A patient who begins GLP-1 therapy often experiences significant fatigue, nausea, and reduced appetite in the early weeks
Amongst other GLP-1R agonists, Exenatide uses a combination of mechanisms which may include glucose-dependent stimulation of insulin secretion, suppression of glucagon secretion, enhancement of -cell mass, slowing of gastric emptying, inhibition of food intake, and modulation of glucose trafficking in peripheral tissues (Nielsen, 2004)
GLP-1 drugs offer a powerful tool for individuals struggling with obesity who may not be candidates for surgery or who have not achieved success with lifestyle modifications alone
A.JamesS